BONJESTA ER 20-20 MG TABLET

doxylamine succinate and pyridoxine hydrochloride
$11.1131per EA
High Outlier

Strength

20; 20 mg/1; mg/1

NDC

55494012060

Classification

Brand

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Last Updated

4/22/2026

Approval Type

New Drug (NDA)

FDA Application

NDA209661

On Market Since

2/19/2018

Pharmacological Classes

Analogs/Derivatives [Chemical/Ingredient]
Antihistamine
Histamine Receptor Antagonists
Vitamin B 6 [Chemical/Ingredient]
Vitamin B6 Analog

Price History

1W

0.0%

1M

+0.0%

3M

-0.1%

6M

+0.0%

1Y

-0.2%

3Y

-0.6%

5Y

+4.1%

All

+12.6%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.